ERBB2 and breast carcinoma: Similar to Akt1 inhibition, Akt3 deficiency also promotes breast cancer cells migration, invasion and metastasis due to upregulation of S100A4 and increased activation of HER2 and discoidin domain receptor tyrosine kinase 1/2 [179, 180].